ZOLL Announces Approval of Next-Generation remedē System for the Treatment of Central Sleep Apnea (Transvenous Phrenic Nerve Stimulation)
The new remedē EL-X model delivers extended longevity, reduced size, and an enhanced suite of diagnostics CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the remedē® EL-X System to treat moderate to […]

